JOHNSON & JOHNSON

JNJ
Delayed Quote. Delayed  - 06/15 04:10:00 pm
164.49USD -0.53%

Turn to zoom
Prev.165.3700
Open165.2300
High165.8600
Low164.3900
Volume4 931 297
Latest news
12h ago
15h ago
16h ago
16h ago
Chart JOHNSON & JOHNSON
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBullish
Resistance171171171
Spread/Res.-3,8%-3,8%-3,8%
Spread/Supp.0,67%3,1%7,9%
Support163159152
Financials
Sales 2021 92 812 M - -
Net income 2021 22 227 M - -
Net Debt 2021 314 M - -
P/E ratio 2021 19,8x
Yield 2021 2,54%
Capitalization 433 B 433 B -
EV / Sales 2021 4,67x
EV / Sales 2022 4,37x
Nbr of Employees 134 500
Free-Float 84,3%
Company
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and...

>> Read more
Sector :
Other Pharmaceuticals
Calendar :
2021-06-23 Special Situation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 183,67 $
Last Close Price 164,49 $
Spread / Highest target 24,0%
Spread / Average Target 11,7%
Spread / Lowest Target -3,95%